Home Pharmaron

Pharmaron

In operation
Post-IPO Round
Life Science R&D Service Provider
Basic
Enterprise Profile
LinkedIn

Basic Information

Pharmaron (Stock Code: 300759.SZ / 3759.HK) is an internationally leading life science R&D service enterprise. Since its establishment in 2004, Pharmaron has been committed to talent cultivation and facility construction, building a comprehensive R&D service system covering various fields such as synthetic and medicinal chemistry, biology, drug metabolism and pharmacokinetics, pharmacology, drug safety evaluation, radiochemistry and radiolabeled metabolism, clinical pharmacology, clinical analytical sciences, clinical CRO and SMO, API and formulation process development, and production services. Pharmaron operates in China, the United States, and the United Kingdom, with over 11,000 employees, providing R&D solutions to partners in North America, Europe, Japan, and China while maintaining excellent cooperative relationships.
Pharmaron Beijing Co.,Ltd.
Beijing,China
more than 500 people
July 01, 2004
pharmaron@pharmaron.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Drug Active Pharmaceutical Ingredients Clinical Trial Institution CRO Chief Medical Officer CDMO
Technology
Targeted Technology Protein Technology
Concept
Therapeutic Products
Application Scenarios
Active Pharmaceutical Ingredient (API) Innovative Drugs AI+Pharmaceuticals